TrialSpark Funding & Investors
New York, NY
TrialSpark is a technology-driven pharma company that runs end-to-end clinical trials, focused on bringing new treatments to patients faster and more efficiently. TrialSpark has built a technology platform that optimizes all aspects of a clinical trial, enabling more efficient trial design, faster trial completion, and higher trial data quality. TrialSpark in-licenses and co-develops drug programs through in-house development, joint ventures, and NewCos.
https://www.trialspark.com/Total Amount Raised: $528,000,000
TrialSpark's Investors
TrialSpark Funding Rounds
Series D
$372,000,000
Series D Investors
Andreessen HorowitzEmerson CollectiveSequoia CapitalLachy GroomThrive CapitalFPV Venturessanofi-aventisSV AngelSeries C
$156,000,000
Series C Investors
Lachy GroomSam AltmanS32Sound VenturesSequoia CapitalThrive CapitalSpark CapitalCasdin CapitalDragoneer Investment GroupFelicisJohn DoerrArrowMark Colorado HoldingsHyphen Capital
Funding info provided by Diffbot.